Douglas J. Manion - Aug 1, 2022 Form 3 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
ACRS
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
3
Date filed
8/2/2022, 05:06 PM
Previous filing
Mar 11, 2022
Next filing
Feb 3, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24.1 - Power of Attorney